Cargando…
Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021–January 2022: A retrospective, population-based, matched cohort study
BACKGROUND: A rapid increase in incidence of the SARS-CoV-2 Omicron variant (sub-lineage BA.1) occurred in France in December 2021, while the Delta variant was prevailing since July 2021. We aimed to determine whether the risk of a severe hospital event following symptomatic SARS-CoV-2 infection dif...
Autores principales: | Auvigne, Vincent, Vaux, Sophie, Strat, Yann Le, Schaeffer, Justine, Fournier, Lucie, Tamandjou, Cynthia, Montagnat, Charline, Coignard, Bruno, Levy-Bruhl, Daniel, Parent du Châtelet, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121907/ https://www.ncbi.nlm.nih.gov/pubmed/35611065 http://dx.doi.org/10.1016/j.eclinm.2022.101455 |
Ejemplares similares
-
Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France
por: Tamandjou Tchuem, Cynthia Raissa, et al.
Publicado: (2023) -
Effectiveness of second booster compared to first booster and protection conferred by previous SARS-CoV-2 infection against symptomatic Omicron BA.2 and BA.4/5 in France
por: Tamandjou, Cynthia, et al.
Publicado: (2023) -
First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022
por: Maisa, A., et al.
Publicado: (2022) -
Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022
por: Suarez Castillo, Milena, et al.
Publicado: (2022) -
Burden of influenza, healthcare seeking behaviour and hygiene measures during the A(H1N1)2009 pandemic in France: a population based study
por: Van Cauteren, Dieter, et al.
Publicado: (2012)